PodBites

”PodBites” is a podcast-style segment under the PAL Bites program designed to help medical students master key diagnostic concepts in minutes. Each episode focuses on comparing two closely related diseases, breaking down their causes, symptoms, diagnostic findings, and treatments in a clear, concise, and engaging way. Join us on a journey through the human body, where each organ, system, and pathway is brought to life and presented to you in bite-sized form for your convenience Get ready to dive into the world of medicine with our crystal cut explanations and vibrant illustrations. We’ll see you soon!🍐

Listen on:

  • Apple Podcasts
  • YouTube
  • Podbean App
  • Spotify

Episodes

Neuroscience | Sleep Disorders

Tuesday Mar 17, 2026

Tuesday Mar 17, 2026

🍐 In this episode of PodBites, Tala Alkhalaf is joined by Lana Hossari and Nour Alatassi to explore the fascinating world of sleep physiology and sleep disorders.
✨ This episode is also PodBites’ first-ever trio episode, featuring one host and two voice actors, bringing a dynamic and engaging approach to understanding the science behind sleep and its disruptions.
🎙️ Tune in to explore:
The physiology of sleep, including the mechanisms that regulate the sleep–wake cycle and circadian rhythm
The different stages of sleep (REM and non-REM) and their roles in brain and body function
Insomnia and hypersomnia, and how sleep disruption affects cognition, mood, and daily functioning
Narcolepsy, including hallmark features such as cataplexy, sleep paralysis, and hypnagogic hallucinations
Sleep apnea, its pathophysiology, clinical presentation, and long-term health consequences
Parasomnias, including sleepwalking, night terrors, and REM behavior disorder
The clinical approach to recognizing, diagnosing, and managing common sleep disorders
🌟 A clear and clinically practical guide to understanding sleep disorders — connecting sleep physiology, clinical symptoms, and real-world diagnosis to help you recognize these conditions with confidence.

Tuesday Mar 17, 2026

🍐 In this episode of PodBites, Mohammed Seifuldein and Youssef Shimy unpack the complex science behind substance-related disorders, explaining how addictive substances hijack the brain’s reward circuitry and reshape behavior, motivation, and decision-making.
🎙️ Tune in to explore:
How addiction begins in the brain’s reward pathway, where dopamine travels from the ventral tegmental area (VTA) to the nucleus accumbens, reinforcing behaviors that feel rewarding
Why drugs create massive dopamine surges followed by deep crashes, driving cravings and compulsive drug use
How addiction rewires the brain through glutamate-driven drug memories, environmental triggers, and loss of frontal lobe control
Major risk factors for addiction, including genetics, early age of exposure, trauma, and underlying mental health conditions
Alcohol use disorder, including withdrawal stages, delirium tremens, and complications like Wernicke–Korsakoff syndrome and dilated cardiomyopathy
Key treatment principles for alcoholism such as thiamine before glucose, benzodiazepines for withdrawal, and medications like naltrexone, acamprosate, and disulfiram
Cannabis and its active components (THC and CBD), including effects on the amygdala, reward pathways, appetite, and long-term brain development
Stimulants such as methamphetamine and cocaine, their powerful dopamine effects, and life-threatening complications including vasoconstriction, myocardial infarction, and hyperthermia
Opioids and their mechanisms, including activation of opioid receptors, dopamine release, and the risk of fatal respiratory depression in overdose
The unique effects of psychedelics like LSD and psilocybin, which cause hallucinations and altered perception without causing classic addiction
🌟 A clear, neuroscience-driven guide to addiction, helping listeners understand how substances reshape brain circuitry, behavior, and health — and why effective treatment requires compassion, prevention, and evidence-based care.

Tuesday Mar 17, 2026

🍐 In this episode of PodBites, Mariam Gurashi and Aylin Nurioglu explore the complex world of eating disorders, connecting neuroscience, psychology, and clinical medicine to explain how disruptions in the brain’s reward system can lead to harmful eating behaviors and serious medical complications.
🎙️ Tune in to explore:
How dopamine-driven reward pathways in the brain influence eating behavior and why food normally activates the VTA–nucleus accumbens reward circuit
The role of the prefrontal cortex and stress hormones in impulse control and how cortisol can weaken decision-making during emotional stress
Anorexia nervosa, including severe food restriction, distorted body image, and the life-threatening systemic effects of prolonged starvation
The widespread complications of starvation, including amenorrhea, bradycardia, anemia, osteoporosis, and muscle wasting
The dangerous metabolic shifts seen in refeeding syndrome, particularly hypophosphatemia during nutritional rehabilitation
Bulimia nervosa, characterized by binge eating followed by compensatory behaviors such as vomiting, laxative use, or excessive exercise
Classic clinical findings such as Russell’s sign, dental enamel erosion, and hypokalemia-related arrhythmias
Binge eating disorder, where recurrent binge episodes occur without purging, often driven by emotional distress rather than hunger
The link between binge eating and dopamine reward signaling, emotional triggers, and impaired impulse control
Evidence-based management strategies including cognitive behavioral therapy, pharmacologic treatments, appetite-modulating medications, and metabolic interventions
🌟 A clinically grounded and neuroscience-informed guide to understanding eating disorders — helping learners recognize how brain circuits, emotional regulation, and medical complications intersect in these complex psychiatric conditions.

Tuesday Mar 17, 2026

🍐 In this episode of PodBites, Lamar Antari and Leen Al-Fadhel take listeners into the world of antipsychotic pharmacology, using clinical stories and neuroscience principles to explain how these medications help manage schizophrenia and other psychotic disorders.
🎙️ Tune in to explore:
The core symptom domains of schizophrenia — positive, negative, and cognitive symptoms
The dopamine hypothesis of schizophrenia and how imbalances in dopamine signaling contribute to psychosis
The four major dopamine pathways: mesolimbic, mesocortical, nigrostriatal, and tuberoinfundibular
How first-generation (typical) antipsychotics like haloperidol and chlorpromazine primarily work through D₂ receptor blockade
The major extrapyramidal side effects (EPS) including dystonia, akathisia, parkinsonism, and tardive dyskinesia
Important adverse effects such as hyperprolactinemia, orthostatic hypotension, sedation, and neuroleptic malignant syndrome
How second-generation (atypical) antipsychotics such as risperidone, quetiapine, aripiprazole, and clozapine target both dopamine and serotonin receptors
The trade-off between lower EPS risk but higher metabolic complications, including weight gain, insulin resistance, and dyslipidemia
Unique clinical features of key drugs like clozapine for treatment-resistant schizophrenia and the need for regular CBC monitoring due to agranulocytosis risk
🌟 A high-yield, clinically grounded guide to understanding how antipsychotics affect brain pathways, improve symptoms of psychosis, and why balancing efficacy with side-effect management is essential in psychiatric pharmacotherapy.

Tuesday Mar 17, 2026

🍐 In this episode of PodBites, Host Mamon Yaser and Voice Actor Abdulrahman Mohammed walk listeners through the spectrum of stress-related psychiatric disorders, exploring how traumatic or overwhelming life events can lead to significant psychological and physical symptoms.
🎙️ Tune in to explore:
The body’s psychological and physiological response to stress and how traumatic experiences affect mental health
Acute Stress Disorder (ASD) and how it develops shortly after a traumatic event
Post-Traumatic Stress Disorder (PTSD), including its core symptom clusters: intrusion, avoidance, negative mood/cognition, and hyperarousal
The clinical features that help differentiate normal stress reactions from pathological stress disorders
The concept of trauma exposure and the types of events most commonly associated with stress-related conditions
The role of dissociation, flashbacks, and emotional numbing in trauma-related disorders
Risk factors, course of illness, and long-term psychological impact of untreated trauma
Core principles of management, including psychotherapy approaches and pharmacologic treatments when needed
🌟 A clear and clinically relevant guide to understanding how severe stress and trauma can reshape mental health — helping learners recognize the symptoms and principles behind diagnosing and managing stress-related disorders.

Neuroscience | CNS Tumors

Tuesday Mar 17, 2026

Tuesday Mar 17, 2026

🍐 In this episode of PodBites, Abdelrahman Lachize and Omar Kobrosly take listeners on a comprehensive journey through the pathology of central nervous system (CNS) tumors. From fundamental diagnostic principles to the most important tumor types, this episode breaks down how brain tumors are classified, identified, and understood in clinical medicine.
🎙️ Tune in to explore:
The unique behavior of CNS tumors and why even benign tumors can be dangerous due to the confined space of the skull
Key diagnostic clues such as age, tumor location, imaging findings, and histopathology
The difference between intra-axial tumors (arising within brain tissue) and extra-axial tumors (arising outside the brain)
The major group of gliomas, including astrocytomas, oligodendrogliomas, and ependymomas
The progression of astrocytomas from pilocytic astrocytoma (Grade I) to glioblastoma (Grade IV) and the defining features of aggressive tumors such as necrosis and endothelial proliferation
Classic histologic patterns used in diagnosis, including Rosenthal fibers, fried-egg cells, pseudorosettes, whorled patterns, and psammoma bodies
Pediatric tumors like medulloblastoma, their aggressive nature, and their ability to spread through cerebrospinal fluid
Important extra-axial tumors such as meningiomas, including their characteristic histology and clinical presentation
The role of molecular markers such as IDH mutations and 1p/19q co-deletion in prognosis and treatment decisions
Why metastatic tumors are actually the most common brain tumors in adults
🌟 A high-yield and clinically oriented overview of CNS tumor pathology — helping you connect neuroanatomy, histology, imaging, and clinical presentation to better recognize and understand these complex diseases.

Tuesday Mar 17, 2026

🍐 In this episode of PodBites, Maya Ibrahim and Manal Abdelrahim guide you through the pharmacology behind antidepressants and mood stabilizers, breaking down how these medications alter brain chemistry to treat major depressive disorder and bipolar disorder. Together, they explore the key drug classes used in clinical practice and the mechanisms that help restore balance to neurotransmitter systems in the brain.
🎙️ Tune in to explore:
The monoamine hypothesis of depression and the role of serotonin and norepinephrine in mood regulation
Tricyclic antidepressants (TCAs) and why they’re considered “dirty drugs” due to multiple receptor effects
The classic 3 Cs of TCA overdose: Coma, Convulsions, and Cardiotoxicity
Selective serotonin reuptake inhibitors (SSRIs) and why they became the safer first-line treatment
Common SSRI side effects including sexual dysfunction, gastrointestinal symptoms, and discontinuation syndrome
Serotonin–norepinephrine reuptake inhibitors (SNRIs) and how they bridge older and newer antidepressant therapies
Monoamine oxidase inhibitors (MAOIs) and the famous “cheese effect” caused by tyramine-induced hypertensive crisis
The fundamentals of bipolar disorder management, including Lithium as the gold-standard mood stabilizer
Why lithium requires careful monitoring due to its narrow therapeutic index and risk of toxicity
🌟 A clear and high-yield guide to understanding how modern psychiatry uses pharmacology to treat mood disorders — connecting neurochemistry, drug mechanisms, and clinical practice to help you master these essential medications.

Tuesday Mar 17, 2026

🍐 In this episode of PodBites, Mamon Yaser and Abdulrahman Mohammed break down the pharmacology behind anti-epileptic drugs (AEDs) — exploring how these medications stabilize neuronal activity, prevent abnormal electrical discharges, and help control seizures across different epilepsy types.
🎙️ Tune in to explore:
The basic pathophysiology of seizures and how abnormal neuronal firing leads to epileptic activity
The major mechanisms of anti-epileptic drugs, including sodium channel blockade, calcium channel inhibition, and enhancement of GABA-mediated inhibition
Key drug classes such as phenytoin, carbamazepine, valproate, lamotrigine, levetiracetam, and ethosuximide
How specific AEDs are chosen based on seizure type (focal vs generalized)
Important pharmacokinetic properties, including drug metabolism and enzyme induction
Major side effects and toxicities, including teratogenicity, hepatotoxicity, and CNS effects
Clinical considerations when initiating, adjusting, or combining anti-epileptic therapy
🌟 A high-yield and clinically practical guide to understanding anti-epileptic medications — helping you connect neurophysiology, pharmacology, and clinical decision-making when managing patients with seizures.

Saturday Mar 14, 2026

🍐 In this episode of PodBites, Mamon Yaser and Abdulrahman Mohammed explore a fascinating group of conditions that sit at the intersection of psychology and physical health — disorders where emotional distress manifests as physical symptoms. Together, they unpack how the brain processes fear, stress, and emotion, and how these processes can shape the way illness is experienced and expressed.
🎙️ Tune in to explore:
The concept of somatization and how emotional stress can manifest as real physical symptoms
The role of the limbic system and amygdala in amplifying fear and bodily sensations
Important psychological defense mechanisms such as undoing and regression
Somatic Symptom Disorder, including its diagnostic criteria and clinical presentation
llness Anxiety Disorder and how it differs from somatic symptom disorder
Functional Neurological Disorder (conversion disorder) and how emotional stress can lead to neurological symptoms like paralysis or blindness
Factitious Disorder, where symptoms are intentionally produced to assume the sick role
The importance of clinical context, symptom awareness, and patient intent in differentiating these disorders
Key management approaches, including cognitive behavioral therapy, social support, and careful clinical validation
🌟 A thought-provoking and clinically relevant discussion that helps bridge psychiatry and medicine — reminding us that understanding patients means listening not only to their symptoms, but also to the stories behind them.

Tuesday Mar 10, 2026

🍐 In this episode of PodBites, Muhsin Ali and Mohammad AbdulRahim guide you through demyelinating diseases, with a special focus on Multiple Sclerosis (MS) — exploring how immune-mediated destruction of myelin disrupts neural signaling and leads to the neurological symptoms seen in this classic exam and clinical condition.
🎙️ Tune in to explore:
The structure and function of myelin, and how it enables rapid saltatory conduction along axons
The key difference between demyelinating diseases and dysmyelinating disorders (leukodystrophies)
The immune-mediated pathophysiology of MS, including autoreactive T cells, macrophages, and B-cell antibody production
Why oligodendrocytes in the CNS are the primary targets of autoimmune attack
The formation of demyelinating plaques in the white matter, and their classic periventricular distribution
How MS lesions appear on MRI (T2 hyperintense plaques) and why contrast enhancement indicates active inflammation
The characteristic histologic findings, including foamy macrophages, perivascular lymphocytes, and gliosis
The clinical patterns of MS, including relapsing–remitting, primary progressive, secondary progressive, and benign MS
Common neurological manifestations such as optic neuritis, weakness, sensory changes, gait disturbance, and bladder dysfunction
The three pillars of MS diagnosis: clinical criteria (McDonald criteria), MRI findings, and CSF analysis showing oligoclonal IgG bands
🌟 A structured, high-yield guide to understanding multiple sclerosis — connecting neuroanatomy, immunology, pathology, and clinical presentation to help you recognize this important neurological disease with confidence.

Copyright 2024 All rights reserved.

Podcast Powered By Podbean

Version: 20241125